Tag: Lung Cancer Drug
Merck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC
Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA) as a first-line option for ... Read More
Novartis lung cancer drug Zykadia gets US FDA priority review
Swiss pharma Novartis has announced that its lung cancer drug Zykadia (ceritinib) has been granted the FDA priority review for its expanded use as the ... Read More